semaglutide gut microbiome Bidirectional Interactions Between the Microbiota and Incretin-Based Therapies GLP‐1 agonists and the gut

Wanting Children (01:54:58) Church, Activities, Small Groups & Dating

GLP-1 (Semaglutide): Reduces appetite Slows gastric emptying Increases satiety Supports sustainable calorie reduction Average weight loss: Up to 15% in 68 weeks (NEJM 2021) GLP-1 + GIP (Tirzepatide): GLP-1 + GIP synergy boosts insulin sensitivity Enhances metabolic balance Further suppresses appetite and cravings Average weight loss: Up to 21% in 72 weeks (SURMOUNT-1) Compounded vs

Who This Is For

PMID: 31319771

The phenolic constituents of edible mushrooms possess the ability to reduce the risk of multiple human disorders

YinWLfMChenRHultmanCMFangFSandinS